Eli Lilly | LLY - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
AbbVie USD 33.3B 29.71B 2026-06
Abbott USD 4.68B 439M 2026-03
ALKERMES USD 107.69M 35.17M 2026-09
Amgen USD 20.83B 17.97B 2026-09
AstraZeneca USD 23.57B 679M 2026-09
Baxter International USD 1.02B 10M 2026-09
Biogen USD 430.3M 26.4M 2026-09
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Coherus Biosciences USD 13.17M 1.69M 2026-06
Drreddys Laboratories INR 36.08B 13.72B 2026-09
Eli Lilly USD 5.79B 319M 2026-09
Gilead Sciences USD 934M 260M 2026-09
GlaxoSmithKline GBP 15.63B 1.29B 2026-09
Glaxosmithkline GBP 15.63B 1.3B 2026-09
J&J USD 9.32B 94M 2026-09
Medtronic USD 2.7B 51M 2026-06
Merck USD 5.03B 1.2B 2026-09
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Novartis USD 4.24B 15M 2026-09
Novartis USD 4.24B 79M 2026-09
Novo Nordisk DKK 14.59B 212M 2026-06
Perrigo USD 390.5M 9.9M 2026-09
Pfizer USD 4.07B 511M 2026-09
Phibro Animal Health USD 136.45M 9.13M 2026-09
Prestige Brands USD 44.02M 7.17M 2026-09
Regeneron Pharmaceuticals USD 1.14B 19M 2026-09
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 24.55B 957M 2026-09
Sanofi EUR 23.6B 888M 2026-06
United Therapeutics USD 520.2M 22.4M 2026-09
Zoetis USD 419M 33M 2026-09